Frequency of BCL2 and BCL6 translocations in follicular lymphoma: Relation with histological and clinical features

References

• Armitage J O, Weisenburger D D. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998; 16: 2780–2795
   PubMed Web of Science ®Google Scholar
• Biagi J J, Seymour J F. Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood 2002; 99: 4265–4275
   PubMed Web of Science ®Google Scholar
• Dave S S, Wright G, Tan B, Rosenwald A, Gascoyne R D, Chan W C, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004; 351: 2159–2169
   PubMed Web of Science ®Google Scholar
• Roulland S, Navarro J M, Grenot P, Milili M, Agopian J, Montpellier B, et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med 2006; 203: 2425–2431
   PubMed Web of Science ®Google Scholar
• Marsden V S, Strasser A. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 2003; 21: 71–105
   PubMed Web of Science ®Google Scholar
• de Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 2005; 23: 6358–6363
   PubMed Web of Science ®Google Scholar
• Meijerink J P. t(14;18), a journey to eternity. Leukemia 1997; 11: 2175–2187
   PubMed Web of Science ®Google Scholar
• Luminari S, Federico M. Prognosis of follicular lymphomas. Hematol Oncol 2006; 24: 64–72
   PubMed Web of Science ®Google Scholar
• Pathology and Genetic of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, LyonsFrance 2001; 162–167
   Google Scholar
• Shaffer A L, Yu X, He Y, Boldrick J, Chan E P, Staudt L M. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 2000; 13: 199–212
   PubMed Web of Science ®Google Scholar
• Solal-Celigny P, Roy P, Colombat P, White J, Armitage J O, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood 2004; 104: 1258–1265
   PubMed Web of Science ®Google Scholar
• Buske C, Hoster E, Dreyling M, Hasford J, Unterhalt M, Hiddemann W. The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome. Blood 2006; 108: 1504–1508
   PubMed Web of Science ®Google Scholar
• Arcaini L, Colombo N, Passamonti F, Burcheri S, Orlandi E, Brusamolino E, et al. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment. Leuk Res 2006; 30: 277–282
   PubMed Web of Science ®Google Scholar
• Plancarte F, Lopez-Guillermo A, Arenillas L, Montoto S, Gine E, Muntanola A, et al. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients. Eur J Haematol 2006; 76: 58–63
   PubMed Web of Science ®Google Scholar
• Montoto S, Lopez-Guillermo A, Ferrer A, Camos M, Alvarez-Larran A, Bosch F, et al. Survival after progression in patients with follicular lymphoma: analysis of prognostic factors. Ann Oncol 2002; 13: 523–530
   PubMed Web of Science ®Google Scholar
• Montoto S, Lopez-Guillermo A, Colomer D, Esteve J, Bosch F, Ferrer A, et al. Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma. Leuk Lymphoma 2003; 44: 71–76
   PubMed Web of Science ®Google Scholar
• Alvaro T, Lejeune M, Camacho F I, Salvado M T, Sanchez L, Garcia J F, et al. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma. Haematologica 2006; 91: 1605–1612
   PubMed Web of Science ®Google Scholar
• A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar
• Garcia J F, Maestre L, Lucas E, Sanchez-Verde L, Romero-Chala S, Piris M A, et al. Genetic immunization: a new monoclonal antibody for the detection of BCL-6 protein in paraffin sections. J Histochem Cytochem 2006; 54: 31–38
   PubMed Web of Science ®Google Scholar
• Buno I, Nava P, Alvarez-Doval A, Alvarez-Rodriguez F, Diez-Martin J L, Menarguez J. Lymphoma associated chromosomal abnormalities can easily be detected by FISH on tissue imprints. An underused diagnostic alternative. J Clin Pathol 2005; 58: 629–633
   PubMed Web of Science ®Google Scholar
• Lopez-Guillermo A, Cabanillas F, McDonnell T I, McLaughlin P, Smith T, Pugh W, et al. Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma. Blood 1999; 93: 3081–3087
   PubMed Web of Science ®Google Scholar
• Jardin F, Gaulard P, Buchonnet G, Contentin N, Lepretre S, Lenain P, et al. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics. Leukemia 2002; 16: 2309–2317
   PubMed Web of Science ®Google Scholar
• Ott G, Katzenberger T, Lohr A, Kindelberger S, Rudiger T, Wilhelm M, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 2002; 99: 3806–3812
   PubMed Web of Science ®Google Scholar
• Bosga-Bouwer A G, van den Berg A, Haralambieva E, de Jong D, Boonstra R, Kluin P, et al. Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B: a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?. Hum Pathol 2006; 37: 528–533
   PubMed Web of Science ®Google Scholar
• Karube K, Guo Y, Suzumiya J, Sugita Y, Nomura Y, Yamamoto K, et al. CD10(−)MUM1(+) follicular lymphoma lacks BCL2 translocation and shows characteristic biological and clinical features. Blood 2007; 109: 3076–3079
   PubMed Web of Science ®Google Scholar
• Sekiguchi N, Kobayashi Y, Yokota Y, Kusumoto S, Tanimoto K, Watanabe T, et al. Follicular lymphoma subgrouping by fluorescence in situ hybridization analysis. Cancer Sci 2005; 96: 77–82
   PubMed Web of Science ®Google Scholar
• Cattoretti G, Pasqualucci L, Ballon G, Tam W, Nandula S V, Shen Q, et al. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell 2005; 7: 445–455
   PubMed Web of Science ®Google Scholar
• Yang X, Lee K, Said J, Gong X, Zhang K. Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: implications for malignant transformation. Blood 2006; 108: 2006–2012
   PubMed Web of Science ®Google Scholar